Physician profile
Eric Serrano
NPI 1508852468
$10,814.06
in general payments reported to CMS, 2019-2025
54 companies · $1,594 in 2025
The $1,594 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,047 · 2020: $1,259 · 2021: $2,164 · 2022: $1,780 · 2023: $1,448 · 2024: $1,523 · 2025: $1,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,564.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,795.15 | 2019-2025 | Ubrelvy, Qulipta, Linzess |
| Astrazeneca Pharmaceuticals LP | $1,759.88 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $551.19 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Ibsa Pharma INC. | $528.72 | 2020-2025 | Tirosint, Licart, Licart |
| Abbott Laboratories | $391.74 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Bausch Health US, LLC | $371.62 | 2019-2023 | Aplenzin, Wellbutrin |
| Biohaven Pharmaceuticals, INC. | $338.64 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $336.93 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $328.03 | 2019-2023 | Belsomra, Segluromet, Steglujan |
| Pfizer INC. | $322.56 | 2019-2025 | |
| Exact Sciences Corporation | $315.65 | 2023-2025 | Cologuard Collection Kit |
| Antares Pharma, INC. | $296.56 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Biohaven Pharmaceutical Holding Company LTD. | $235.88 | 2022 | |
| Lilly USA, LLC | $221.50 | 2019-2025 | Mounjaro, Kisunla, Zepbound |
| Allergan, INC. | $218.72 | 2019-2020 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Serrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.